NYMX Nymox Pharmaceutical Corporation

2.09
+0.09  (+5%)
Previous Close 2
Open 2.06
Price To Book 19
Market Cap 135173375
Shares 64,676,256
Volume 192,475
Short Ratio
Av. Daily Volume 93,818

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Data released February 2016 met endpoint
NX-1207 long-term NX03-0040 trial
Low grade localized prostate cancer
http://www.globenewswire.com/news-release/2019/04/16/1804960/0/en/Nymox-Reports-Pre-NDA-CMC-Meeting-with-the-FDA.html
NX-1207 Fexapotide
BPH